Expert Interview
A Second Opinion: Looking at the topline results of the Phase 2 MISSION trial of zetomipzomib in Lupus Nephritis patients
Ticker(s): KZR, GSK, AUPHInstitution: Northwell Health
- Chief of the Division of Rheumatology at Northwell Health.
- Directs The Program in Novel Therapeutics, the Health System’s clinical research program in musculoskeletal disease and the Hospital’s SLE and Autoimmune Disease Treatment Center, which has become internationally recognized for its role in the development of new therapies for SLE.
- Treats 200+ patients with Lupus Nephritis.
- Clinical research in the area of anti-rheumatic drug development.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
